1. Home
  2. LEE vs CTMX Comparison

LEE vs CTMX Comparison

Compare LEE & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • CTMX
  • Stock Information
  • Founded
  • LEE 1890
  • CTMX 2008
  • Country
  • LEE United States
  • CTMX United States
  • Employees
  • LEE N/A
  • CTMX N/A
  • Industry
  • LEE Newspapers/Magazines
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • CTMX Health Care
  • Exchange
  • LEE Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • LEE 39.6M
  • CTMX 444.3M
  • IPO Year
  • LEE N/A
  • CTMX 2015
  • Fundamental
  • Price
  • LEE $6.61
  • CTMX $2.39
  • Analyst Decision
  • LEE
  • CTMX Strong Buy
  • Analyst Count
  • LEE 0
  • CTMX 2
  • Target Price
  • LEE N/A
  • CTMX $5.00
  • AVG Volume (30 Days)
  • LEE 33.7K
  • CTMX 2.4M
  • Earning Date
  • LEE 07-31-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • LEE N/A
  • CTMX N/A
  • EPS Growth
  • LEE N/A
  • CTMX 128.27
  • EPS
  • LEE N/A
  • CTMX 0.49
  • Revenue
  • LEE $591,094,000.00
  • CTMX $147,557,000.00
  • Revenue This Year
  • LEE N/A
  • CTMX N/A
  • Revenue Next Year
  • LEE N/A
  • CTMX N/A
  • P/E Ratio
  • LEE N/A
  • CTMX $4.91
  • Revenue Growth
  • LEE N/A
  • CTMX 23.81
  • 52 Week Low
  • LEE $5.83
  • CTMX $0.40
  • 52 Week High
  • LEE $19.63
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • LEE 49.78
  • CTMX 52.18
  • Support Level
  • LEE $6.04
  • CTMX $2.36
  • Resistance Level
  • LEE $7.19
  • CTMX $2.79
  • Average True Range (ATR)
  • LEE 0.38
  • CTMX 0.17
  • MACD
  • LEE 0.08
  • CTMX -0.02
  • Stochastic Oscillator
  • LEE 55.73
  • CTMX 44.25

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: